Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide
- PMID: 11348625
- DOI: 10.1016/s0014-2999(01)00946-3
Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide
Abstract
The dermorphin-derived peptide [Dmt(1)]DALDA (H-Dmt-D-Arg-Phe-Lys-NH(2)), labels mu-opioid receptors with high affinity and selectivity in receptor binding assays. In mouse, radiant heat tail-flick assay [Dmt(1)]DALDA produced profound spinal and supraspinal analgesia, being approximately 5000- and 100-fold more potent than morphine on a molar basis, respectively. When administered systemically, [Dmt(1)]DALDA was over 200-fold more potent than morphine. Pharmacologically, [Dmt(1)]DALDA was distinct from morphine. [Dmt(1)]DALDA displayed no cross-tolerance to morphine in the model used and it retained supraspinal analgesic activity in morphine-insensitive CXBK mice. Supraspinally, it also differed from morphine in its lack of sensitivity towards naloxonazine. Finally, in antisense mapping studies, [Dmt(1)]DALDA was insensitive to MOR-1 exon probes that reduced morphine analgesia, implying a distinct receptor mechanism of action. Thus, [Dmt(1)]DALDA is an interesting and extraordinarily potent, systemically active peptide analgesic, raising the possibility of novel approaches in the design of clinically useful drugs.
Similar articles
-
[Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.Curr Med Chem. 2002 Jan;9(1):31-9. doi: 10.2174/0929867023371445. Curr Med Chem. 2002. PMID: 11860345
-
Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.J Pharmacol Exp Ther. 2003 May;305(2):696-702. doi: 10.1124/jpet.102.048561. Epub 2003 Jan 24. J Pharmacol Exp Ther. 2003. PMID: 12606628
-
Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.Pharmacology. 2009;83(1):33-7. doi: 10.1159/000167878. Epub 2008 Nov 6. Pharmacology. 2009. PMID: 18987489 Free PMC article.
-
Opioid peptide-derived analgesics.AAPS J. 2005 Oct 14;7(3):E560-5. doi: 10.1208/aapsj070356. AAPS J. 2005. PMID: 16353933 Free PMC article. Review.
-
Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine.Peptides. 2011 Feb;32(2):421-7. doi: 10.1016/j.peptides.2010.11.013. Epub 2010 Nov 30. Peptides. 2011. PMID: 21126548 Review.
Cited by
-
Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt1]DALDA, and KGOP01, Binding to the mu Opioid Receptor.Molecules. 2020 Apr 29;25(9):2087. doi: 10.3390/molecules25092087. Molecules. 2020. PMID: 32365707 Free PMC article.
-
Pharmacological profiles of opioid ligands at kappa opioid receptors.BMC Pharmacol. 2006 Jan 25;6:3. doi: 10.1186/1471-2210-6-3. BMC Pharmacol. 2006. PMID: 16433932 Free PMC article.
-
Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery.Biomolecules. 2022 Sep 5;12(9):1241. doi: 10.3390/biom12091241. Biomolecules. 2022. PMID: 36139079 Free PMC article. Review.
-
[Dmt(1)]DALDA analogues modified with tyrosine analogues at position 1.Bioorg Med Chem Lett. 2016 Aug 1;26(15):3629-31. doi: 10.1016/j.bmcl.2016.06.003. Epub 2016 Jun 3. Bioorg Med Chem Lett. 2016. PMID: 27301366 Free PMC article.
-
Tolerance develops in spinal cord, but not in brain with chronic [Dmt1]DALDA treatment.Br J Pharmacol. 2004 Dec;143(8):987-93. doi: 10.1038/sj.bjp.0706007. Epub 2004 Nov 22. Br J Pharmacol. 2004. PMID: 15557286 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials